SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending with significant upward momentum, fueled by community enthusiasm and a narrative linking it to Ethereum's resurgence.  Discussions revolve around a prophecy involving $YEE alongside $DOGE and $PEPE, with many believing it's poised for substantial growth and drawing comparisons to past meme coin successes. The community emphasizes $YEE's potential within the Ethereum ecosystem, with some anticipating exchange listings and broader market recognition.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

AVGO is trending downwards despite strong earnings, with discussions centered on margin compression, customer concentration, and whether the AI boom is sustainable. The community is debating whether this is a buying opportunity or a sign of broader issues in the AI sector, while analysts offer price target upgrades.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending due to excitement surrounding potential FDA guidance and a possible buyout, fueled by positive trial data and insider enthusiasm. The community is buzzing about a potential "BABO" (Big-Ass-Buy-Out) and the significance of recent biomarker data, using the term "brownies" as a playful reference. Investors are closely watching for news that could validate the company's prospects in the liver disease treatment space, leading to increased trading volume and speculation.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain ($ARBK) is trending due to its reverse stock split and significant price drop, sparking discussions around short squeeze opportunities. The community is focused on its volatility and potential as a low float runner, while acknowledging its recent restructuring and London Stock Exchange delisting. Traders are weighing the risks and potential rewards amid the company's efforts to avoid insolvency.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed social media attention surrounding a prior AI server deal and its low float after a reverse split, sparking discussions of a potential short squeeze. The community is actively discussing entry points, technical indicators signaling a breakout, and comparing it to other low-float runners. Bullish sentiment is fueled by the stock's recent price action and the possibility of a parabolic move if volume increases.

Forget What You Know. This is Qubic.  Qubic is a decentralised Layer 1 network, where unmatched scalable tech meets artificial general intelligence (AGI), purpose built from the ground up to transcend the traditional limitations of blockchain.  Qubic is redefining blockchain with feeless transactions and instant finality, and a unique PoW model (Useful Proof of Work) that channels computational power toward AI training, rather than wasting it. This is a network where mining serves a higher purpose.  Qubic's network can empower industries such as finance, gaming, and supply chain management with real-time, cost-free transactions. Its architecture enables high-performance dApps encouraging developers to build reliable and scalable solutions.   Useful Proof of Work (uPoW): Unlike traditional PoW, which wastes vast amounts of energy, uPoW focuses computational power on AI training, making mining meaningful.   Aigarth Initiative: Aigarth lies at the core of Qubic's mission to achieve AGI. Through this initiative, computational power is generated by a global network of miners and channelled via UPoW towards artificial intelligence training with the aim of developing AGI by 2027. Aigarth represents Qubic's vision of a decentralised, community-powered AI network where advancements in AI are accessible to all, not controlled by any single interest.  Bare Metal Architecture: Running directly on bare metal hardware, removing the need for an operating system, enables Qubic to maximise performance, enabling unmatched scalability and high-volume processing.  Instant Finality: Qubic's sub-second finality ensures nearly instantaneous transactions, essential for applications needing real-time performance.   Feeless Transactions: Qubic’s zero-fee model eliminates cost barriers, encouraging wider adoption and participation.   Smart Contracts and IPOs: Qubic boasts the world’s fastest smart contracts, achieving up to 55 million transfers per second. It also redefines smart contracts. Investors can bid for shares when a new Qubic smart contract is released via an IPO.    Quorum Consensus: Inspired by Leslie Lamport’s Byzantine Fault Tolerance, Qubic’s Quorum design ensures security and resilience even if some nodes fail. With foundations in Nick Szabo’s decentralised trust principles, Qubic’s governance prevents any single entity from gaining control, maintaining a secure and truly decentralised network.  Become part of the Qubic ecosystem, where decentralised blockchain and AI unite. Visit our website, become a miner or a developer, or engage with the Qubic community as we work together to redefine blockchain technology and AI for a new era.

Qubic 

Qubic is trending as the community discusses its potential in artificial general intelligence (AGI) and innovative technology. Conversations revolve around its unique approach to quorum-based transactions and its possible role in the future of crypto. Some users are excited about the project's recent performance and potential listings on larger exchanges.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending due to positive Phase 3 trial results for relacorilant in ovarian cancer, sparking discussions of a potential new standard of care and market opportunities. Bullish sentiment is fueled by potential FDA approval, leading to speculation about a short squeeze and future revenue, although some caution against overvaluation. The community is focused on the potential for significant growth and the impact on short sellers.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is seeing increased discussion as investors assess its recent price action and potential future. Community members are debating whether it's a pump and dump scheme or a long-term hold with upcoming catalysts, while also closely watching its performance relative to competitors like AAVE. Concerns around the treasury's runway and governance issues are also driving the conversation.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BCTX is trending due to recent presentation of Phase 2 survival and Phase 3 clinical data at SABCS, highlighting promising results for its Bria-IMT regimen in metastatic breast cancer, although some investors express concerns about dilution and the company's history of offerings. The community is actively debating the potential for a breakthrough in cancer treatment versus skepticism regarding the company's financials and management. Discussions also include the company's cash runway and potential for a buyout.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is gaining traction due to its high throughput, processing millions of transactions per second, and its potential to become a compliant infrastructure solution for traditional finance. The project's interoperability with other chains and integration with a Stripe company, Bridge, are also key talking points. Community discussions revolve around Keeta's infrastructure edge and possible undervaluation compared to competitors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BAC looking strong with call buyers stepping up

Seeing a big April 2026 $57.5 call sweep for $432k, signaling some serious upside interest

Not just short term hype, institutions are positioning for the long haul

RBC boosts their target to $59 and Morgan Stanley holds at $68

Stock is hitting new 52-week highs in the mid $54s

All signs pointing to bullish sentiment

Options traders might want to keep an eye on those targets for planning exits

StockTwits Web

Bank of America Corp

 looking strong with call buyers stepping up

Seeing a big April 2026 $57.5 call sweep for $432k, signaling some serious upside interest

Not just short term hype, institutions are positioning for the long haul

RBC boosts their target to $59 and Morgan Stanley holds at $68

Stock is hitting new 52-week highs in the mid $54s

All signs pointing to bullish sentiment

Options traders might want to keep an eye on those targets for planning exits

What buyers? Nobody is buying Bank of America. They are buying back their own stock. Don’t be an idiot.@QuantInsider

StockTwits for iOS

What buyers? Nobody is buying Bank of America. They are buying back their own stock. Don’t be an idiot.